Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5, Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea.
Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5, Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea; School of Chemical Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.
J Control Release. 2017 Dec 10;267:223-231. doi: 10.1016/j.jconrel.2017.09.015. Epub 2017 Sep 14.
In cancer theranostics, the main strategy of nanoparticle-based targeted delivery system has been understood by enhanced permeability and retention (EPR) effect of macromolecules. Studies on diverse nanoparticles provide a better understanding of different EPR effects depending on their structure, physicochemical properties, and chemical modifications. Recently the tumor microenvironment has been considered as another important factor for determining tumor-targeted delivery of nanoparticles, but the correlation between EPR effects and tumor microenvironment has not yet been fully elucidated. Herein, ectopic subcutaneous tumor models presenting different tumor microenvironments were established by inoculation of SCC7, U87, HT29, PC3, and A549 cancer cell lines into athymic nude mice, respectively. In the five different types of tumor-bearing mice, tumor-targeted delivery of self-assembled glycol chitosan nanoparticles (CNPs) were comparatively evaluated to identify the correlation between the tumor microenvironments and targeted delivery of CNPs. As a result, neovascularization and extents of intratumoral extracellular matrix (ECM) were both important in determining the tumor targeted delivery of CNPs. The EPR effect was maximized in the tumors which include large extent of angiogenic blood vessels and low intratumoral ECM content. This comprehensive study provides substantial evidence that the EPR effects based tumor-targeted delivery of nanoparticles can be different depending on the tumor microenvironment in individual tumors. To overcome current limitations in clinical nanomedicine, the tumor microenvironment of the patients and EPR effects in clinical tumors should also be carefully studied.
在癌症治疗学中,基于纳米粒子的靶向递药系统的主要策略已经通过大分子的增强渗透和保留(EPR)效应得到了理解。对不同纳米粒子的研究提供了对不同 EPR 效应的更好理解,这取决于它们的结构、物理化学性质和化学修饰。最近,肿瘤微环境已被认为是决定纳米粒子肿瘤靶向递药的另一个重要因素,但 EPR 效应与肿瘤微环境之间的相关性尚未完全阐明。在此,通过将 SCC7、U87、HT29、PC3 和 A549 癌细胞系分别接种到裸鼠中,建立了具有不同肿瘤微环境的异位皮下肿瘤模型。在五种不同类型的荷瘤小鼠中,比较了自组装的乙二醇壳聚糖纳米粒子(CNPs)的肿瘤靶向递药,以确定肿瘤微环境与 CNPs 靶向递药之间的相关性。结果表明,新生血管化和肿瘤内细胞外基质(ECM)的程度在决定 CNPs 的肿瘤靶向递药中都很重要。EPR 效应在包含大量血管生成血管和低肿瘤内 ECM 含量的肿瘤中达到最大。这项综合研究提供了充分的证据,表明基于 EPR 效应的纳米粒子肿瘤靶向递药可以因个体肿瘤中的肿瘤微环境而有所不同。为了克服临床纳米医学中的当前局限性,还应仔细研究患者的肿瘤微环境和临床肿瘤中的 EPR 效应。